22344736

Sir-Petermann T

2012

Relationship between anti-M?llerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.

22345006

Tang XH

2012

Reproductive traits of polycystic ovary syndrome in female rhesus monkeys.

22349439

Qu F

2012

A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells.

22350529

Eftekhar M

2012

Successful pregnancy following a novel endometrial preparation in a PCOS patient undergoing IVM: a case report.

22353191

Nakatsuka M

2012

Response to comment on 'Increased arterial stiffness in mildly-hypertensive women with polycystic ovary syndrome'.

22355193

Dogan MI

2013

Abdominal obesity is associated with a lower ankle-brachial index in women with polycystic ovary syndrome.

22355432

Rachad M

2011

Ovarian hyperstimulation syndrome in a spontaneous pregnancy with invasive mole: report of a case.

22356026

Nazir F

2011

Polycystic ovaries in adolescent girls from Rawalpindi.

22356187

Capalbo A

2012

The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2?7-fold increased risk of polycystic ovary syndrome in a Sardinian population.

22357073

McFarland C

2012

Treating polycystic ovary syndrome and infertility.

22357766

Kim JJ

2012

Prevalence of elevated glycated hemoglobin in women with polycystic ovary syndrome.

22358341

Melo AS

2012

[Women with polycystric ovary syndrome have a higher frequency of metabolic syndrome regardless of body mass index].

22359978

Orbetzova MM

2011

Effect of short-term standard therapeutic regimens on neuropeptide Y and adipose tissue hormones in overweight insulin-resistant women with polycystic ovary syndrome.

22360920

Beller JP

2013

Cardiovascular risk and combined oral contraceptives: clinical decisions in settings of uncertainty.

22363895

Mazloomi S

2012

Association between Hypoadiponectinemia and Low Serum Concentrations of Calcium and Vitamin D in Women with Polycystic Ovary Syndrome.

22365339

Guzman L

2012

Developmental capacity of in vitro-matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm.

22367584

Deniz R

2012

Nesfatin-1 and other hormone alterations in polycystic ovary syndrome.

22367984

Haoula Z

2012

Evaluating the association between endometrial cancer and polycystic ovary syndrome.

22373955

Davies MJ

2012

Birthweight and thinness at birth independently predict symptoms of polycystic ovary syndrome in adulthood.

22375190

Khademi A

2010

The Effect of Exercise in PCOS Women Who Exercise Regularly.

22375502

Strandberg Y

2011

[Polycystic ovarian syndrome].

22375613

Ghazeeri GS

2012

Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview.

22375718

Barber TM

2012

The link between polycystic ovary syndrome and both Type 1 and Type 2 diabetes mellitus: what do we know today?

22376149

Motta AB

2012

The role of obesity in the development of polycystic ovary syndrome.

22381227

Wang L

2012

The expression of sex steroid synthesis and inactivation enzymes in subcutaneous adipose tissue of PCOS patients.

22382613

Weickert MO

2012

Neuroendocrine and endocrine dysfunction in the hyperinsulinemic PCOS patient: the role of metformin.

22382641

Xi W

2012

Correlation of serum Anti-M?llerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients.

22382934

Glintborg D

2012

Age associated differences in prevalence of individual rotterdam criteria and metabolic risk factors during reproductive age in 446 caucasian women with polycystic ovary syndrome.

22384174

Dasgupta S

2012

Association of CAPN10 SNPs and haplotypes with polycystic ovary syndrome among South Indian Women.

22384417

Park JC

2011

Endometrial histology and predictable clinical factors for endometrial disease in women with polycystic ovary syndrome.

22384426

Kim CH

2011

Pioglitazone treatment decreases follicular fluid levels of tumor necrosis factor-? and interleukin-6 in patients with polycystic ovary syndrome.

22384427

Han AR

2011

Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study.

22384540

Lian F

2011

[Progress and debates of polycystic ovary syndrome treated by integrative medicine].

22384551

Liang C

2011

[Controlling effect of bushen huatan compound on the insulin signal conducting molecule inside ovaries in polycystic ovary syndrome model rats].

22385110

Schmidt J

2012

Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome - a long-term follow-up study.

22385136

Kowalska I

2012

Impact of the FTO gene variation on fat oxidation and its potential influence on body weight in women with polycystic ovary syndrome.

22386763

Costa F

2012

Influence of Val16Ala SOD2 polymorphism on the in-vitro effect of clomiphene citrate in oxidative metabolism.

22387621

Armanini D

2012

Polycystic ovary syndrome: Implications of measurement of plasma aldosterone, renin activity and progesterone.

22388330

Sirmans SM

2012

Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications.

22389004

Saxena R

2013

Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes.

22390153

Rivero R

2012

Protein expression of PKCZ (Protein Kinase C Zeta), Munc18c, and Syntaxin-4 in the insulin pathway in endometria of patients with polycystic ovary syndrome (PCOS).

22392485

Abu Hashim H

2012

Clomiphene citrate alternatives for the initial management of polycystic ovary syndrome: an evidence-based approach.

22397743

Olszanecka-Glinianowicz M

2012

Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?

22397748

Zhu W

2012

Repeat transvaginal ultrasound-guided ovarian interstitial laser treatment improved the anovulatory status in women with polycystic ovarian syndrome.

22398257

Perales-Puchalt A

2012

Threshold values of follicle count for the definition of PCO.

22402209

Guo M

2012

Comparison of the phenotype of Chinese versus Dutch Caucasian women presenting with polycystic ovary syndrome and oligo/amenorrhoea.

22405326

Maryam K

2012

The comparison of insulin resistance frequency in patients with recurrent early pregnancy loss to normal individuals.

22406517

Boztosun A

2012

Serum levels of angiopoietin-related growth factor (AGF) are increased in polycystic ovary syndrome.

22407189

Deveci HS

2012

Histological evaluation of rat larynx in experimental polycystic ovary syndrome model.

22408172

Purcell SH

2012

Insulin-stimulated glucose uptake occurs in specialized cells within the cumulus oocyte complex.

22409701

Verit FF

2012

The prevalence of metabolic syndrome in clomiphene citrate resistant polycystic ovary syndrome.

22418753

Iftikhar S

2012

Risk of cardiovascular events in patients with polycystic ovary syndrome.

22419702

Morin-Papunen L

2012

Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial.

22419715

Tosi F

2012

Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome.

22420627

Russo N

2012

Polycystic ovary syndrome: brain-derived neurotrophic factor (BDNF) plasma and follicular fluid levels.

22421560

Sanfilippo JS

2012

NASPAG 25 years later.

22421986

Racho? D

2012

Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome.

22424626

Miao ZL

2012

The intervention effect of Rosiglitozone in ovarian fibrosis of PCOS rats.

22424820

Comerford KB

2012

Lean mass and insulin resistance in women with polycystic ovary syndrome.

22427353

Escobar-Morreale HF

2012

Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS.

22428202

Ellenbogen A

2011

[In vitro maturation of oocytes: a novel method of treatment of patients with polycystic ovarian syndrome undergoing in vitro fertilization].

22428379

Koskela-Koivisto T

2012

[Bariatric surgery and reproductive health].

22428626

Sun L

2012

Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients.

22428986

Kol S

2012

The gonadotropin-releasing hormone antagonist protocol--the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation.

22429116

Mohiyiddeen L

2012

PCOS and peripheral AMH levels in relation to FSH receptor gene single nucleotide polymorphisms.

22429289

Martiny C

2012

Psychiatric disorders in patients with end-stage renal disease.

22431566

Misso ML

2012

Aromatase inhibitors for PCOS: a systematic review and meta-analysis.

22432496

Faucher MA

2012

Closer surveillance in pregnancy for women with polycystic ovary syndrome may be merited.

22437766

Pontes AG

2012

[Insulin resistance in women with polycystic ovary syndrome: relationship with anthropometric and biochemical variables].

22439384

Curry A

2012

Better care for PCOS. Studying women's genes to find out what works.

22440264

Seow KM

2012

Antim?llerian hormone: a marker for prediction of ovarian function and polycystic ovary syndrome.

22441212

Seow KM

2012

Expression levels of vascular cell adhesion molecule-1 in young and nonobese women with polycystic ovary syndrome.

22441797

Hsueh AJ

2012

Ovarian Kaleidoscope database: ten years and beyond.

22442260

Evans JJ

2012

Balancing ovulation and anovulation: integration of the reproductive and energy balance axes by neuropeptides.

22443151

Kowalczyk R

2012

Psychological gender of patients with polycystic ovary syndrome.

22443257

Kim JJ

2012

Polycystic ovary syndrome is not associated with polymorphisms of the TCF7L2, CDKAL1, HHEX, KCNJ11, FTO and SLC30A8 genes.

22445321

Moncayo R

2012

Inadequate description of an acupuncture treatment study for polycystic ovaries.

22447143

Aydogdu A

2012

The relationship of epicardial adipose tissue thickness to clinical and biochemical features in women with polycystic ovary syndrome.

22447309

Del Prete M

2012

Insulin resistance and acne: a new risk factor for men?

22448702

Vrb?kov? J

2012

[A recommended approach to evaluate cardiovascular risk and to prevent cardiovascular diseases and type 2 diabetes mellitus in women with polycystic ovary syndrome].

22450347

Koiou E

2012

Plasma von Willebrand factor antigen levels are elevated in the classic phenotypes of polycystic ovary syndrome.

22451180

Ziaee A

2012

Effect of metformin and pioglitazone treatment on cardiovascular risk profile in polycystic ovary syndrome.

22452173

Kedikova S

2011

[Myoinositol--alternative treatment of insulin resistance in adolescents].

22452370

Moini A

2012

Association of thrombophilia and polycystic ovarian syndrome in women with history of recurrent pregnancy loss.

22453059

Rahimi-Ardabili H

2013

Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency.

22454796

Blay SL

2011

A case of major depressive disorder and symptoms of polycystic ovary syndrome responding to escitalopram.

22455684

Chen ZJ

2012

[New understanding of genetics of polycystic ovary syndrome].

22455685

Li Y

2012

[Effect of follicle stimulating hormone on the secretion of anti-mullerian hormone in the granulosa cells in patients with polycystic ovarian syndrome].

22455686

Yang Y

2012

[Correlation between interleukin-1 and the obesity of polycystic ovary syndrome].

22455687

Xu YP

2012

[Clinical application of in vitro maturation of human immature oocytes for infertile women with polycystic ovary syndrome].

22455688

Zhang HY

2012

[Activation and significance of the PI3K/Akt pathway in endometrium with polycystic ovary syndrome patients].

22456311

Pepene CE

2012

Soluble platelet/endothelial cell adhesion molecule (sPECAM)-1 is increased in polycystic ovary syndrome and related to endothelial dysfunction.

22462015

G?uszak O

2012

Phenotype and metabolic disorders in polycystic ovary syndrome.

22462531

Du Q

2012

A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome.

22464207

Abdel-Rahman MY

2012

Polycystic ovary syndrome and diabetes screening: a survey of gynecologists and reproductive endocrinologists.

22464410

Vieira CS

2012

The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.

22464806

Ardabili HR

2012

Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.

22466427

Mourikis H

2007

[Polycystic ovary syndrome].

22468791

Yun JH

2012

Association between INS-VNTR polymorphism and polycystic ovary syndrome in a Korean population.

22468948

Rajagopal G

2012

Effect of lifestyle modification and metformin therapy on emerging cardiovascular risk factors in overweight Indian women with polycystic ovary syndrome.